Most global investors assume that if a sector is worth investing in, a US-listed stock covers it. For most sectors, that assumption is correct. But six major Korean themes have no meaningful US-listed equivalent — meaning the only way to access them is to buy directly on the Korean Stock Exchange (KRX).
This guide covers each theme, explains why no US alternative exists, and shows how the valuation stacks up against global peers.
Why “No US Alternative” Matters
When a sector has no US-listed pure play, foreign investors face a choice: find a Korean-listed stock or ETF, or skip the trade entirely.
For many, the default is to skip. That creates a structural discount in Korean markets — and an opportunity for investors willing to cross the KRX.
The six themes below share one key trait: you cannot replicate the exposure through any US brokerage without accessing the Korean market directly.
1. Shipbuilding — The Only Game in Town
Representative stocks: HD Hyundai Heavy Industries, Hanwha Ocean
Korean ETF: TIGER Top10 Shipbuilding (KRX: 450140)
The US has no commercial shipbuilding industry worth investing in. Huntington Ingalls (HII) and General Dynamics build US Navy warships exclusively — they do not compete for LNG carriers or container ships.
Korea controls roughly 40% of the global commercial shipbuilding orderbook, led by HD Hyundai Heavy Industries and Hanwha Ocean. Both companies are winning record contracts for LNG carriers, a vessel type that requires specialized construction capability that China has not yet fully replicated.
Valuation: HD Hyundai Heavy trades at PBR ~1.2x, below the global shipbuilding sector average of ~1.5x.
Why no US alternative? The US merchant marine effectively collapsed after the 1980s. There is no path to a NYSE-listed commercial shipbuilder in the foreseeable future.
2. EV Battery Cells — No US Manufacturer at Scale
Representative stocks: LG Energy Solution, Samsung SDI, SK On (private)
Korean ETF: KODEX 2nd Battery Industry (KRX: 305720)
This surprises most investors: the United States has no large-scale EV battery cell manufacturer listed on a US exchange.
- CATL is Chinese and not US-listed
- Panasonic is Japanese
- QuantumScape and Solid Power are pre-revenue solid-state startups
- Albemarle mines lithium but does not make cells
Korean battery makers — LG Energy Solution, Samsung SDI, and SK On — collectively hold roughly 30% of global EV cell market share. They are the only investable pure plays for foreign investors who want exposure to the battery manufacturing layer of the EV supply chain.
Valuation: LGES trades at ~28x PER vs a global battery sector average of ~25x. A slight premium, but justified by manufacturing scale and IRA-backed US gigafactory expansion.
3. Biologics CDMO — Samsung Biologics Stands Alone
Representative stocks: Samsung Biologics, Celltrion
Korean ETF: TIGER Healthcare (KRX: 143860)
A Contract Development and Manufacturing Organization (CDMO) produces biologics drugs on behalf of pharmaceutical companies. It is one of the fastest-growing segments in healthcare.
The problem for US investors: there is no major US-listed biologics CDMO.
- Lonza is Swiss (SIX: LONN)
- Wuxi Biologics is Hong Kong-listed
- Catalent was the closest US option — and was acquired by Novo Holdings in 2024
Samsung Biologics is the world’s largest single-site biologics CDMO by capacity, with clients including major MNCs across the US and Europe. For investors who want to bet on the biologics outsourcing boom, the KRX is the only destination.
Valuation: Samsung Biologics trades at ~40x PER vs Lonza’s ~35x. A premium, but reflective of its dominant scale position.
4. K-Beauty — A Category, Not Just a Country
Representative stocks: AmorePacific, LG H&H, APR Co.
Korean ETF: TIGER K-Beauty (KRX: 441640)
K-Beauty is not simply “Korean cosmetics.” It is a distinct product philosophy — layered skincare routines, novel ingredients (snail mucin, centella, fermented extracts), and a specific aesthetic — that has created a standalone global consumer category.
The global K-Beauty market was valued at $118 billion in 2025 and is growing at 10% annually.
US-listed beauty companies like Estée Lauder or e.l.f. Beauty benefit indirectly from K-Beauty trends, but none of them offer pure-play exposure to Korean beauty brands. AmorePacific (Laneige, Innisfree) and APR (Medicube) are only accessible via the KRX.
Valuation: AmorePacific trades at ~18x PER vs the global beauty sector average of ~22x — a meaningful discount despite owning brands with accelerating Western market growth.
5. K-Food — Buldak Has No Ticker in New York
Representative stocks: Samyang Foods, Nongshim
Korean ETF: No dedicated ETF yet (available as individual stocks)
Samyang Foods’ Buldak (fire chicken) noodles have become one of the most recognizable food brands globally — viral on TikTok, stocked in Costco, and generating US revenues of $185 million in H1 2025 alone (30% of overseas revenue).
There is no US-listed equivalent for K-Food as an investable category. Nestlé and Campbell Soup make instant noodles, but they do not offer the cultural momentum or brand specificity of Buldak.
Valuation: Samyang Foods trades at ~20x PER, roughly in line with global food peers but arguably undervalued given its 22% operating margins and supply-constrained US demand.
6. Nuclear Plant Construction — Korea Exports What Others Only Plan
Representative stocks: Doosan Enerbility, KEPCO Engineering
Korean ETF: HANARO Nuclear Power (KRX: 446720)
Nuclear power is returning as a serious energy source. But most Western investors buying “nuclear stocks” are buying power generators (Constellation Energy, Vistra) or pre-revenue SMR developers (NuScale, Oklo) — neither of which actually builds nuclear plants.
Korea is the only country currently exporting complete, operating nuclear power plants. The APR1400 reactor design is proven, delivered on time and on budget in the UAE, and now targeted for deployment in the Czech Republic, Poland, and elsewhere.
NuScale’s SMR is not expected to generate meaningful commercial revenue until 2027 at the earliest. Doosan Enerbility is supplying components for nuclear plants being built right now.
Valuation: Doosan Enerbility trades at ~20x PER vs a global nuclear equipment average of ~22x. Modest discount for the only proven nuclear EPC capability outside of China and Russia.
How to Buy These Stocks as a Foreign Investor
All six themes are accessible via the Korean Stock Exchange (KRX). The most common route for international investors is Interactive Brokers (IBKR), which offers direct KRX access through its standard platform.
- Open an IBKR account (same process as for US stocks)
- Search the ticker or ETF name
- Select Exchange: KSE (Korea Stock Exchange)
- Place the order in KRW — IBKR handles currency conversion automatically
From mid-2026, Webull users will also be able to trade Korean stocks directly, following its partnership with Kiwoom Securities announced in February 2026.
Frequently Asked Questions
Are Korean stocks safe for foreign investors?
The KRX is a regulated exchange with full foreign investor access. The main risks are currency (KRW/USD) and lower English-language disclosure compared to US markets.
Do I need a Korean brokerage account?
No. IBKR provides direct KRX access. Webull is adding this capability in 2026.
Which Korean ETF should I buy for each theme?
See the Market Themes page on K-Stock Radar for up-to-date ETF recommendations and performance data for each sector.
Is EWY a good substitute?
EWY (iShares MSCI South Korea ETF) gives broad Korea exposure but is heavily weighted toward Samsung Electronics and SK Hynix. It does not give targeted exposure to shipbuilding, K-Beauty, CDMO, or K-Food.
The Bottom Line
The six themes above — shipbuilding, EV batteries, biologics CDMO, K-Beauty, K-Food, and nuclear construction — share a rare characteristic: they cannot be accessed through any US-listed stock or ETF at meaningful scale.
For global investors looking to diversify beyond US equities without chasing emerging market risk, these Korean themes offer a compelling combination of global market leadership and direct KRX accessibility.
Explore all Korean themes with live ETF data: radar.korean-stocks.com/themes
Data as of June 2026. Valuation multiples are approximate based on consensus estimates. This article is for informational purposes only and does not constitute investment advice.
